Tashkent, Uzbekistan (UzDaily.com) — A preliminary report on the master plan of the Biotechnological Cluster project, implemented under intergovernmental cooperation with the Ministry of Land, Infrastructure and Transport of the Republic of Korea and the Korean state corporation KIND (Korea Overseas Infrastructure & Urban Development), was discussed in Tashkent.

During the meeting, representatives of Uzbekistan’s Pharmaceutical Industry Development Agency presented their comments and proposals regarding the structure of the master plan and responded to inquiries from the Korean side.

The project is being carried out as part of the K-City Network Global Cooperation Program with the involvement of the Agency for Innovative Development and the Pharmaceutical Industry Development Agency. The sides had earlier agreed on the development of a Smart Bio-Cluster in Tashkent, which includes the drafting of a master plan, a preliminary feasibility study, and a roadmap for implementation, followed by the engagement of Korean investors and companies.

Following the talks, the delegation visited the Tashkent Pharma Park, an innovative scientific and industrial pharmaceutical cluster, to familiarize themselves with ongoing projects and prospects for cooperation. The guests also toured the site allocated for the construction of the Smart Bio-Cluster and received a detailed briefing on its infrastructure and alignment with project requirements.

Additionally, the delegation visited the Grand Logistics center owned by Grand Pharm. At the 36,000-square-meter facility, guests were introduced to the distribution system and fully automated processes based on the SAP platform and compliant with GDP (Good Distribution Practice) standards.